|
Asselsa Small & Mid Caps Switzerland SRI
|
|
CH0016421205
|
PMG Fonds Management AG
|
Equities
|
Switzerland
|
All sectors
|
CHE
|
|
|
|
Cancer Charity Support Fund Moderate
|
|
CH0102924906
|
PMG Fonds Management AG
|
Asset Allocation
|
Balanced (33% - 50% equities)
|
CHF
|
CHE
|
|
|
|
CG - Global Sust. Fund of Fund A
|
|
CH0027677761
|
PMG Fonds Management AG
|
Equities
|
All countries
|
Ethics consciousness
|
CHE
|
|
|
|
CG - Global Sust. Fund of Fund I
|
|
CH0016216571
|
PMG Fonds Management AG
|
Equities
|
All countries
|
Ethics consciousness
|
CHE
|
|
|
|
ENISO Forte CH SMI Expanded®
|
|
CH0132859700
|
PMG Fonds Management AG
|
Equities
|
Switzerland
|
All sectors
|
CHE
|
|
|
|
ENISO Forte G (CHF)
|
|
CH0000823531
|
PMG Fonds Management AG
|
Equities
|
All countries
|
All sectors
|
CHE
|
|
|
|
ENISO Forte G (EUR)
|
|
CH0018882594
|
PMG Fonds Management AG
|
Equities
|
All countries
|
All sectors
|
CHE
|
|
|
|
PMG Partners Funds - Almira European Equities A
|
|
LU0386768146
|
PMG Fonds Management AG
|
Equities
|
Traditional Europe
|
All sectors
|
LUX
|
|
|
|
PMG Partners Funds - Almira European Equities B
|
|
LU0386768229
|
PMG Fonds Management AG
|
Equities
|
Traditional Europe
|
All sectors
|
LUX
|
|
|
|
PMG Partners Funds - CP Global BioPharma Fund
|
|
LU0426487442
|
PMG Fonds Management AG
|
Equities
|
All countries
|
Biotechnology
|
LUX
|
|
|